semaglutide versus cardiovascular outcomes align more closely with attained dose than achieved weight loss semaglutide vs metformin Efficacy and

Despite robust clinical evidence, barriers such as high costs, limited access, lack of awareness of approved indications, and practitioner hesitancy continue to impede widespread adoption

The curve was still descending: Participants on retatrutide hadn't plateaued at week 48, suggesting final Phase 3 numbers could be higheror that the comparison gap might narrow once both drugs reach equilibrium

And certain antipsychotic medications can affect your weight management and your metabolic control as well

Wessner B, Strasser EM, Koitz N, Schmuckenschlager C, Unger-Manhart N, Roth E

Newcastle-ottawa scale: comparing reviewers to authors assessments

Brain Imaging and Behavior, 10 (2), 581